MRI assessment of hepatocellular carcinoma after locoregional therapy
S. Hussein, Rasha; Yasser A. Abbas; Wahid Tantawy;
Abstract
Liver cirrhosis and hepatocellular carcinoma (HCC) constitute one of the major causes of morbidity, mortality, and high health care costs worldwide. Multiple treatment options are available for HCC depending on the clinical status of the patient, size and location of the tumor, and available techniques and expertise. Locoregional treatment options are multiple. The most challenging part is how to assess the treatment response by different imaging modalities, but our scope will be assessing the response to locoregional therapy for HCC by MRI. This will be addressed by conventional MR methods using LI-RADS v2018 and by functional MR using diffusion-weighted imaging, perfusion, and highlighting the value of the novel intravoxel incoherent motion (IVIM).
Other data
| Title | MRI assessment of hepatocellular carcinoma after locoregional therapy | Authors | S. Hussein, Rasha ; Yasser A. Abbas ; Wahid Tantawy | Keywords | To know the available locoregional therapies for HCC. To compare various criteria for Response Assessment in HCC. To highlight MRI criteria for LI-RADS v2018 in treatment response assessment for each locoregional therapy. To demonstrate some pitfalls in assessment after various available locoregional therapy and the available functional methods for treatment response assessment. Thighlight the novel intravoxel incoherent motion (IVIM) which could be used as quantitative tool. | Issue Date | Jan-2019 | Publisher | SpringerOpen | Journal | Insights into Imaging | DOI | https://doi.org/10.1186/s13244-019-0690-1 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.